glp-1 market - Stock Newsroom

S TOCK newsroom .COM

S&P 500 7,056 +0.15%

DJIA 48,743 +0.20%

Nasdaq 26,352 +0.12%

DAX 24,232 +0.44%

Gold $4,196 +0.16%

Oil $89.67 +0.01%

BTC $75,048 -0.22%

VIX 20.43 -0.11%

EUR/USD 1.1785 -0.02%

ETH $2,336 -0.53%

S&P 500 7,056 +0.15%

DJIA 48,743 +0.20%

Nasdaq 26,352 +0.12%

DAX 24,232 +0.44%

Gold $4,196 +0.16%

Oil $89.67 +0.01%

BTC $75,048 -0.22%

VIX 20.43 -0.11%

EUR/USD 1.1785 -0.02%

ETH $2,336 -0.53%

glp-1 market

Eli Lilly GLP-1 pill concept in a modern lab symbolizing new obesity drug Foundayo

Pharma & Healthcare·Stocks·USA

Eli Lilly GLP-1 pill Foundayo: Can the Boom Last?

By Maik Kemper • Apr 13, 2026

Eli Lilly GLP-1 pill concept in a modern lab symbolizing new obesity drug Foundayo

Pharma & Healthcare·Stocks·USA

Eli Lilly GLP-1 pill Foundayo: Can the Boom Last?

By Maik Kemper • Apr 13, 2026

Can the new Eli Lilly GLP-1 pill Foundayo justify the stock’s rich valuation and extend its obesity drug dominance? Maik Kemper Editor in Chief Conclusion…